| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008393651 |
| P356 | DOI | 10.1038/SJ.ONC.1202987 |
| P8608 | Fatcat ID | release_b4uvhukknrdhdnie5ljj5mbnty |
| P698 | PubMed publication ID | 10498898 |
| P5875 | ResearchGate publication ID | 12801259 |
| P50 | author | Johannes Zuber | Q47713758 |
| P2093 | author name string | Adams V | |
| Sers C | |||
| Schäfer R | |||
| Tchernitsa OI | |||
| Brinckmann R | |||
| Britsch SK | |||
| P2860 | cites work | jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun | Q24302170 |
| Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a | Q24324559 | ||
| Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA | Q24324771 | ||
| cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family | Q24336422 | ||
| Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid | Q24562115 | ||
| Increased expression of the Ras suppressor Rsu-1 enhances Erk-2 activation and inhibits Jun kinase activation | Q24648337 | ||
| Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology | Q24679938 | ||
| Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation | Q28131755 | ||
| Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes | Q28265486 | ||
| A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene | Q28279136 | ||
| Primary structure of a putative serine protease specific for IGF-binding proteins | Q28300113 | ||
| ras genes | Q29547799 | ||
| Positional cloning of the Werner's syndrome gene | Q29618393 | ||
| Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries | Q29618999 | ||
| Gene expression profiles in normal and cancer cells | Q29619943 | ||
| Cloning and identification of genes that associate with mammalian replicative senescence | Q32065345 | ||
| Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene | Q33557109 | ||
| Differentiation of F9 embryonal carcinoma cells induced by the c-jun and activated c-Ha-ras oncogenes | Q33885198 | ||
| Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells | Q34053383 | ||
| Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis | Q34077458 | ||
| Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells | Q34340548 | ||
| Nerve growth factor suppresses the transforming phenotype of human prolactinomas | Q36501758 | ||
| Molecular cloning and characterization of avian sarcoma virus circular DNA molecules | Q36506123 | ||
| Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA | Q36531986 | ||
| Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras | Q36551071 | ||
| Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence | Q36727404 | ||
| A high throughput screening for rarely transcribed differentially expressed genes | Q36865651 | ||
| Hygromycin B Phosphotransferase as a Selectable Marker for DNA Transfer Experiments with Higher Eucaryotic Cells | Q36955921 | ||
| Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein | Q37272242 | ||
| Suppression of tumor growth by senescence in virally transformed human fibroblasts | Q37407629 | ||
| Oncogenes and tumour suppressor genes in transgenic mouse models of neoplasia | Q40877342 | ||
| Characterization of transformation related genes in oral cancer cells | Q41042321 | ||
| SAGE transcript profiles for p53-dependent growth regulation | Q41092725 | ||
| Identification of a major protein kinase C-binding protein and substrate in rat embryo fibroblasts. Decreased expression in transformed cells | Q41215972 | ||
| Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells | Q41354196 | ||
| Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. | Q41460849 | ||
| A new dimension for the human genome project: towards comprehensive expression maps | Q41488796 | ||
| Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes | Q41670302 | ||
| Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells | Q41740694 | ||
| Suppression and re-expression of transformed phenotype in hybrids of HA-ras-1-transformed rat-1 cells and early-passage rat embryonic fibroblasts | Q43552585 | ||
| Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun | Q46914063 | ||
| In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. | Q52834055 | ||
| Increasing complexity of Ras signaling. | Q53429989 | ||
| In vitro growth inhibition of neoplastically transformed cells by non-transformed cells: requirement for gap junctional intercellular communication. | Q53464759 | ||
| Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line | Q59094087 | ||
| PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity | Q67542908 | ||
| Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation | Q70104566 | ||
| Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 | Q71644976 | ||
| P433 | issue | 39 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5448-5454 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators | |
| P478 | volume | 18 |
| Q52057734 | Characterization of progenitor-cell-specific genes identified by subtractive suppression hybridization. |
| Q52015711 | Extracting information from cDNA arrays. |
| Q30868387 | Gene expression profiling of advanced lung cancer |
| Q37004642 | Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer |
| Q40445301 | Identification and validation of differentially expressed genes in neural tube defects of golden hamster induced by hyperthermia using suppression subtractive hybridization |
| Q44189411 | Isolation and characterization of genes associated with the anti-tumor activity of glucocorticoids. |
| Q80130796 | Linking oncogenic pathways with therapeutic opportunities |
| Q38310990 | Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1. |
| Q33930614 | Proteasome- and p38-dependent regulation of ERK3 expression |
| Q41912117 | Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12 |
| Q34125310 | The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells. |
| Q47562619 | Toward the individualization of lung cancer therapy |
Search more.